Secukinumab Drug Survival in Psoriasis and Psoriatic Arthritis Patients: A 24-Month Real-Life Study

Conclusions: Our data confirmed a very good response to secukinumab in both PsO and PsA patients. However, presence of arthritis might affect drug survival.Dermatology

Source: Dermatology - March 9, 2022 Category: Dermatology Source Type: research